Evolent Health to Participate in Upcoming Investor Conferences
WASHINGTON, Feb. 26, 2020 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Executive Officer and Co-Founder Frank Williams, President and Co-Founder Seth Blackley, Chief Financial Officer John Johnson and Executive Vice President, Corporate Performance Nicky McGrane will participate in upcoming investor conferences.
Mr. Williams, Mr. Blackley and Mr. Johnson will present at the Cowen 40th Annual Health Care Conference in Boston on Tuesday, March 3, 2020 at 10:00 a.m. EST. A live audio-only webcast and related presentation materials will be available on the investor relations section of Evolent's website at http://ir.evolenthealth.com/.
Mr. Blackley and Mr. McGrane will attend the Oppenheimer 30th Annual Health Care Conference in New York on Wednesday, March 18, 2020.
About Evolent Health Evolent Health (NYSE: EVH) delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable. Our solutions encompass total cost of care management, specialty care management, and administrative simplification. Evolent serves a national base of leading payers and providers, is the first company to receive the National Committee for Quality Assurance's Population Health Program Accreditation, and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting evolenthealth.com.
Contacts: Bob East or Asher Dewhurst 443.213.0500 Investor Relations [email protected]
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024.
One individual was...